Venture Global Inc VG Q1 2026 Earnings Strong EPS Beat Amid Lack of Revenue Disclosure USBC Q1 2025 Earnings NarrowerThanExpected Loss Fails to Lift Stock NRX Pharmaceuticals Q1 2026 Earnings EPS Miss Marks 114 Surprise Shortfall Stock Surges 20 Purple Biotech Ltd PPBT Q1 2025 Earnings PreRevenue Biotech Reports Narrower Loss as Clinical Progress Continues Marker Therapeutics Inc MRKR Q1 2026 Earnings EPS Beat Expectations Amid Development Stage Operations MSAI Q1 2026 Earnings EPS Surprise Beats Estimates Stock Rises